SPAC607.08c Antibody

What is SPAC607.08c and how is it characterized in research?

SPAC607.08c represents a specific gene/protein target in the fission yeast Schizosaccharomyces pombe proteome. While direct characterization data for SPAC607.08c is limited in the current literature, it shares structural homology with other well-characterized proteins containing the ΨHPC motif (where Ψ represents a hydrophobic amino acid residue) found in E2 enzymes involved in cellular processes. The antibody targeting this protein is classified within immunological research categories, suggesting its relevance to fundamental cellular mechanisms similar to those seen in other SPAC-family proteins involved in stress responses and cellular regulation.

The antibody is identified by catalog number CSB-PA890791XA01SXV-10mg and is manufactured by CUSABIO-WUHAN HUAMEI BIOTECH Co., Ltd. as part of BARIA sro's Life Science portfolio. Research characterization typically involves validation across multiple experimental platforms to confirm specificity and sensitivity for the target epitope.

How does the structure of SPAC607.08c antibody relate to its function?

The SPAC607.08c antibody follows the standard antibody architecture with distinct functional domains:

As an IgG1 subclass antibody, SPAC607.08c antibody exhibits characteristics optimized for antigen neutralization and immunoprecipitation applications. The variable regions contain hypervariable loops that form the antigen-binding site, which determines specificity for the target epitope. The constant regions mediate downstream immune functions such as complement activation, though these are primarily relevant in vivo rather than in research applications.

What experimental methodologies validate SPAC607.08c antibody specificity?

Validating antibody specificity requires multiple orthogonal approaches:

• Western Blot Analysis: Detection of a single band at the expected molecular weight (~20 kDa based on similar E2 enzymes) confirms target specificity . This should be performed in both wildtype and knockout/knockdown systems when possible.

• Immunoprecipitation Validation: The ability to precipitate the target protein from complex lysates, confirmed by mass spectrometry or Western blotting, demonstrates binding capacity and specificity.

• Cross-Reactivity Testing: Testing against related proteins, particularly other SPAC-family proteins such as SPAC227.04, which encodes an Atg10-like protein in S. pombe, helps establish specificity boundaries .

• Epitope Mapping: Modern techniques utilizing AlphaFold2 and molecular docking enable precise epitope prediction, which can be experimentally validated through peptide arrays or hydrogen-deuterium exchange mass spectrometry.

How should SPAC607.08c antibody be optimized for immunoprecipitation studies?

SPAC607.08c antibody is particularly suited for immunoprecipitation applications due to its IgG1 subclass characteristics. For optimal results, follow this methodological approach:

• Lysate Preparation:

  • Harvest cells in mid-log phase from appropriate medium (e.g., EMM for S. pombe studies)

  • Prepare extracts using lysis buffer containing: 50 mM TRIS-HCl pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 10 mM imidazole, protease inhibitors (0.1% leupeptin, 0.1% pepstatin A, 1% aprotinin, 1% PMSF) and phosphatase inhibitors (0.2% Na₃VO₄, 5% NaF)

  • Clear lysates by centrifugation (12,000 × g, 10 minutes, 4°C)

• Antibody Binding:

  • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

  • Add 2-5 μg SPAC607.08c antibody per 500 μg protein lysate

  • Incubate overnight at 4°C with gentle rotation

• Precipitation and Analysis:

  • Add pre-washed Protein A/G beads and incubate for 2-4 hours at 4°C

  • Wash beads 4-5 times with lysis buffer containing reduced detergent concentration

  • Elute proteins by boiling in SDS-PAGE sample buffer

  • Analyze by Western blotting or mass spectrometry

To validate specific binding, include a control IgG antibody precipitation and compare results with known interacting proteins if available.

What protocols are recommended for Western blot analysis using SPAC607.08c antibody?

For detecting SPAC607.08c protein via Western blotting, implement this optimized protocol:

• Sample Preparation:

  • Prepare protein extracts using the lysis buffer described above

  • Quantify protein concentration using Bradford or BCA assay

  • Load 20-50 μg protein per lane on SDS-PAGE gel (12-15% recommended for ~20 kDa proteins)

• Electrophoresis and Transfer:

  • Perform SDS-PAGE separation at 120V until adequate resolution

  • Transfer to nitrocellulose membrane at 100V for 1 hour or 30V overnight at 4°C

• Antibody Incubation:

  • Block membrane with 5% non-fat milk or BSA in TBS-T for 1 hour at room temperature

  • Incubate with SPAC607.08c antibody at 1:1000-1:2000 dilution overnight at 4°C

  • Wash 3x with TBS-T

  • Incubate with HRP-conjugated secondary antibody (1:2000-1:5000) for 1 hour at room temperature

  • Visualize using ECL detection system

• Controls and Validation:

  • Include positive control (tissue/cells known to express target)

  • Include negative control (knockout/knockdown samples if available)

  • Verify band size with molecular weight marker

How can SPAC607.08c antibody be effectively utilized in immunohistochemistry?

For immunohistochemical applications, the following methodological approach optimizes detection:

• Sample Preparation:

  • Fix cells with 4% paraformaldehyde for 15 minutes at room temperature

  • Permeabilize with 0.1% Triton X-100 for 10 minutes

  • Block with 5% normal serum from the species of secondary antibody for 30 minutes

• Antibody Staining:

  • Dilute SPAC607.08c antibody to 1:100-1:500 in blocking buffer

  • Incubate overnight at 4°C in a humidified chamber

  • Wash 3x with PBS

  • Apply fluorophore-conjugated secondary antibody (e.g., FITC-conjugated anti-mouse) at 1:200 dilution

  • Counter-stain nuclei with DAPI

  • Mount with anti-fade mounting medium

• Visualization and Analysis:

  • Image using appropriate filter sets on fluorescence microscope

  • Include controls for autofluorescence and non-specific binding

  • Compare localization patterns with known subcellular markers

This approach allows visualization of the spatial distribution of SPAC607.08c within cells and tissues, providing insights into its potential functional roles.

How does SPAC607.08c relate to stress response pathways?

While direct evidence for SPAC607.08c's role in stress response is not explicitly detailed in the provided literature, insights can be drawn from related proteins in the S. pombe proteome. The homologous protein SpAtg10 (encoded by SPAC227.04) demonstrates critical functions in cellular stress response:

These findings from related proteins suggest potential involvement of SPAC607.08c in stress response pathways, which could be experimentally investigated using similar methodological approaches . To explore SPAC607.08c's role in stress response, researchers should employ:

• Gene deletion/knockdown studies followed by stress challenge experiments

• Protein localization studies under various stress conditions

• Interaction studies to identify stress-dependent binding partners

• Phosphoproteomics to detect post-translational modifications under stress

What computational approaches can enhance SPAC607.08c antibody design and specificity?

Advanced computational methods offer significant advantages for optimizing antibody design and specificity:

• Machine Learning and Supercomputing Approaches:

  • Leveraging computational pipelines that combine machine learning, bioinformatics, and supercomputing can predict optimized antibody structures for specific targets

  • Such approaches have successfully generated antibody sequences within weeks, as demonstrated in SARS-CoV-2 research

• Free Energy Calculations:

  • Tools like FoldX, Rosetta, and molecular dynamics simulations enable evaluation of binding energetics

  • These computational approaches can screen thousands of potential antibody variants rapidly:

    • FoldX for initial screening of mutant antibodies

    • Rosetta for refined energy calculations

    • Molecular dynamics for dynamic binding assessments

    • STATIUM energy prediction tool for final validation

• Epitope Mapping and Specificity Enhancement:

  • Computational prediction of epitopes using AlphaFold2 and molecular docking techniques helps identify specific binding regions

  • These predictions guide targeted mutations to enhance specificity and reduce cross-reactivity

• In Silico Affinity Maturation:

  • Iterative computational mutation and evaluation cycles can identify higher-affinity variants

  • From design spaces of 10^40 potential variants, computational approaches can efficiently identify promising candidates for experimental validation

Implementing these computational approaches requires interdisciplinary collaboration between structural biologists, computational scientists, and immunologists.

How do post-translational modifications affect SPAC607.08c antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of target proteins, presenting both challenges and research opportunities:

• Common PTMs Affecting Recognition:

  • Phosphorylation: Changes charge distribution and potential binding surfaces

  • Glycosylation: Alters accessibility of epitopes and can sterically hinder antibody binding

  • Ubiquitination: Can mask epitopes or create novel recognition sites

• Methodological Approaches to Address PTM Variability:

  • Generate modification-specific antibodies using synthetic peptides with the PTM of interest

  • Employ dephosphorylation assays to confirm phosphorylation-dependent recognition

  • Use deglycosylation enzymes (PNGase F, Endo H) to assess glycosylation effects on binding

  • Compare recognition patterns between native and recombinant proteins

• Validation Strategies:

  • Western blotting with and without phosphatase/deglycosylase treatment

  • Immunoprecipitation followed by mass spectrometry to identify PTMs present on captured proteins

  • Use of site-directed mutagenesis to eliminate specific modification sites

Understanding PTM effects is particularly relevant for proteins involved in signaling pathways and stress responses, as these often undergo dynamic modifications affecting their function and localization.

What are common challenges in SPAC607.08c antibody-based experiments and their solutions?

Researchers commonly encounter several challenges when working with antibodies like SPAC607.08c:

To systematically troubleshoot these issues:

• Perform antibody titration experiments to determine optimal concentration

• Test multiple blocking agents (BSA, milk, serum) to identify optimal conditions

• Include positive and negative controls in every experiment

• Consider alternative detection methods if conventional approaches fail

How can autophagy-related processes be studied using SPAC607.08c and related antibodies?

Given the relationship between some SPAC-family proteins and autophagy pathways, researchers can implement these methodological approaches:

• Autophagy Induction and Monitoring:

  • Induce autophagy by nitrogen starvation: grow cells to mid-log phase in EMM, wash three times in EMM-N, and resuspend in EMM-N

  • Monitor autophagy through Western blotting analysis of marker proteins like Atg8-GFP and free GFP

  • Assess long-term survival during nitrogen starvation by measuring viability at specific time points

• Genetic Interaction Studies:

  • Generate deletion strains using PCR-based approaches with appropriate primers and templates

  • Create double mutants to assess genetic interactions with known autophagy components

  • Perform complementation studies to confirm functional relationships

• Visualization of Autophagy Structures:

  • Use fluorescence microscopy with appropriate markers to visualize autophagy-related structures

  • Implement indirect immunofluorescence using antibodies against autophagy markers

  • Analyze cells using appropriate wavelengths and imaging systems

• Quantitative Assessment:

  • Measure autophagic flux using degradation assays of known autophagy substrates

  • Implement flow cytometry-based approaches for high-throughput analysis

  • Quantify autophagosome formation using image analysis software

These methodologies enable comprehensive investigation of autophagy-related processes and potential involvement of SPAC607.08c in these pathways.

What controls are essential for validating SPAC607.08c antibody specificity?

Rigorous validation requires implementation of multiple controls:

• Genetic Controls:

  • SPAC607.08c knockout/knockdown samples serve as negative controls

  • Overexpression systems provide positive controls with enhanced signal

  • Comparative analysis with related genes (e.g., SPAC227.04) helps establish specificity

• Biochemical Controls:

  • Peptide competition assays confirm epitope specificity

  • Pre-adsorption controls identify non-specific binding

  • Isotype control antibodies detect Fc-mediated interactions

• Cross-Species Controls:

  • Testing across evolutionary related species validates conservation of recognition

  • Heterologous expression systems confirm specificity in different contexts

• Technical Controls:

  • Secondary antibody-only controls identify background signal

  • Multiple detection methods (fluorescence vs. chemiluminescence) confirm signal authenticity

  • Batch-to-batch consistency testing ensures reproducibility

Implementing these controls in a systematic manner ensures confidence in experimental results and facilitates troubleshooting when unexpected outcomes occur.

How might emerging antibody technologies enhance SPAC607.08c research?

Several emerging technologies hold promise for advancing SPAC607.08c research:

• Single-Domain Antibodies and Nanobodies:

  • Smaller antibody fragments offer improved penetration into cellular compartments

  • Enhanced stability allows for more robust experimental applications

  • Simplified recombinant production enables precise engineering

• Proximity Labeling Approaches:

  • Antibody-enzyme fusions (e.g., APEX2, BioID) enable identification of proximal proteins

  • These approaches reveal spatial organization and interaction networks

  • Time-resolved studies capture dynamic protein interactions in response to stimuli

• Antibody-Based Biosensors:

  • Conformation-sensitive antibodies detect structural changes in target proteins

  • FRET-based antibody pairs enable real-time monitoring of protein dynamics

  • Antibody-reporter enzyme fusions allow in vivo activity monitoring

• Super-Resolution Microscopy Applications:

  • Site-specific fluorophore conjugation enhances spatial resolution

  • Multi-color imaging reveals co-localization with unprecedented precision

  • Live-cell compatible antibody fragments enable dynamic studies

These technologies expand the research toolkit beyond traditional applications, enabling deeper insights into SPAC607.08c function and regulation.

What are the current knowledge gaps regarding SPAC607.08c function?

Several significant knowledge gaps remain in understanding SPAC607.08c:

• Functional Characterization:

  • Precise biochemical activity and substrates remain to be fully elucidated

  • Regulatory mechanisms controlling expression and activation need investigation

  • Cell type-specific roles and expression patterns require systematic study

• Interaction Networks:

  • Comprehensive interactome mapping is needed to place SPAC607.08c in cellular pathways

  • Dynamic changes in interaction partners under different conditions remain unexplored

  • Functional consequences of identified interactions require validation

• Structural Insights:

  • High-resolution structural data would enable rational design of research tools

  • Conformational dynamics during functional cycles need characterization

  • Structure-function relationships require systematic mutational analysis

• Physiological Significance:

  • Relevance to specific cellular processes and stress responses needs clarification

  • Potential conservation of function across species requires comparative studies

  • Therapeutic or diagnostic implications remain to be explored

Addressing these knowledge gaps will require integrated approaches combining genetics, biochemistry, structural biology, and systems-level analyses.

How can researchers contribute to improving SPAC607.08c antibody resources?

The research community can enhance antibody resources through collaborative approaches:

• Standardized Validation:

  • Implement comprehensive validation protocols across multiple experimental systems

  • Share validation data through public repositories and publications

  • Develop consensus guidelines for antibody characterization

• Resource Development:

  • Generate knockout validation materials and make them broadly available

  • Create tagged versions of SPAC607.08c for parallel validation studies

  • Develop complementary tools like recombinant proteins and peptide standards

• Technology Implementation:

  • Apply emerging computational approaches to antibody design and optimization

  • Leverage machine learning to predict optimal applications and conditions

  • Implement advanced screening methodologies to identify high-performance antibodies

• Knowledge Sharing:

  • Document experimental conditions in greater detail in publications

  • Contribute to antibody databases with application-specific information

  • Participate in community efforts to benchmark antibody performance

These collective efforts will significantly enhance the quality and utility of SPAC607.08c antibody resources, accelerating research progress in this field.